Live · 13 Sep 2026 SPX 7,656.98 +0.86% NDX 29,368.44 +0.91% VIX 15.84 -11.21% GOLD 4,390.00 +0.58% CL 99.99 -2.43% BTC 77,135.67 +0.74%
NAS100 29,368 +0.91% S&P 7,657 +0.86% GOLD $4,390 +0.58% BTC $77,136 +0.74% VIX 15.84 −11.21% live tape · as of 10:31 UTC
Vol. II · No. 256Sunday, 13 September 2026
TTitan Protect
The Screen · Healthcare · Aerospace & Defense

BiomX Inc

PHGE · NYSE AMERICAN · USD · Market cap $2M · 20 employees

BiomX Inc., a holding company, focuses on defense, security, and critical infrastructure technologies.

FAIL · Does not pass the screen
0.20 USD

At the last full screen
2025-12-31

Screened 2025-12-31 · the tape above runs as of 10:31 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

The Label · The Season, Not the Day

This name holds its markup label.

BiomX Inc holds its Markup at $0.20. Elevated stress, defensive posture warranted, held for 7 days.

As held on the ledger · 2025-12-31
PhaseMarkup
Quantitative stateElevated stress, defensive posture warranted, held for 7 days
Price at the screen$0.20
ValuationN/A trailing · -0.03 forward price to earnings
Values screenFAIL · score 70.0
Beta1.31
The Workings

Five Screens, Shown in Full

Does not pass. Business activity: weapons

TestFigureLimitWhat it meansStatus
Business activity Excluded Core business clean Its core business involves an activity the values screen does not clear. Fail
Debt load 24.83% Below 33% Interest-bearing debt is just 24.8% of its assets, well under the one-third ceiling: it does not run on borrowed money. Pass
Interest-bearing cash 0.00% Below 33% Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. Pass
Receivables 75.39% Below 49% Money owed to the company is 75.4% of assets, above the 49% limit. Fail
Revenue purity Excluded Below 5% of revenue comes from non-compliant sources, over the 5% line. Fail

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Business, in Plain Words
The fundamentals · plain-English read
Forward P/E0.0x
EPS, trailing-23.30
EPS, forward-6.01
Profit margin0.0%currently unprofitable
Return on equity-403.8%not currently earning a positive return on equity
FCF yield-695.05%
Current ratio1.24adequate liquidity, worth monitoring
Beta1.31moves a little more than the market
Short interest, float0.08%
52-week range0.19 - 13.70
MoatNONE
Market cap$2M
Employees20

The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it already moves more than the market on an average day.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

PHGE trades on NYSE AMERICAN. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-09-09 Markdown · changed $0.20 +0.0% Entry 5

The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 93%. Our forward projection puts the odds of a 10% gain over the next month near 16%.

2026-08-08 Distribution · changed $0.20 -62.7% Entry 4

The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 62.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 93%. Our forward projection puts the odds of a 10% gain over the next month near 16%.

2026-07-18 Markup $0.54 +0.0% Entry 3

The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 93%. Our forward projection puts the odds of a 10% gain over the next month near 16%.

2026-07-03 Markup $0.54 +0.0% Entry 2

The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.

2026-07-02 Markup $0.54 Entry 1

The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Related Securities · Others in PHGE's Space

Screened names in the same industry · explore each on its own page.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $0.68 -6.4% · $936 -6.4%
2 months $2.89 -78.1% · $219 -78.1%
3 months $6.37 -90.1% · $99 -90.1%
6 months $2.45 -74.2% · $258 -74.2%
1 year $8.55 -92.6% · $74 -92.6%
2 years $66.50 -99.1% · $10 -99.1%
3 years $67.45 -99.1% · $9 -99.1%
5 years $1,136.20 -99.9% · $1 -99.9%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever PHGE does next, these words stay.

BiomX Inc · PHGE · Markup · $0.20
Recorded 2025-12-31 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.